P. Schanzenbächer

Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators.

Maria Halbrügge, Claudia B Friedrich, Martin Eigenthaler et al. · Journal of Biological Chemistry · 1990 · 271 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Specific Impairment of Human Platelet P2Y _AC ADP Receptor–Mediated Signaling by the Antiplatelet Drug Clopidogrel

Jörg Geiger, J. Brich, Petra Hönig‐Liedl et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 213 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)

Andreas Bonz, Björn Lengenfelder, Jörg Strotmann et al. · Journal of the American College of Cardiology · 2002 · 119 citations · Full text

Medicine, Cardiology, Pharmacology +16

Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors

Jörg Geiger, Petra Hönig‐Liedl, P. Schanzenbächer et al. · European Journal of Pharmacology · 1998 · 84 citations

Medicine, Hematology, Pharmacology +16

Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP- and cGMP-elevating factors

Christiané Nolte, Martin Eigenthaler, P. Schanzenbächer et al. · Journal of Biological Chemistry · 1991 · 64 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16